Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| ERIS | 926.25(0.0%) | 12,574 | 5.2 | 32.6 | 17.3 | 18.3 |
| ASTRAZEN | 4763.35(0.0%) | 11,909 | 18.2 | 77.9 | 24.5 | 18.1 |
| NATCOPHARM | 785.4(-0.3%) | 14,058 | 2.7 | 12.5 | 18.1 | 15.7 |
| APLLTD | 751.15(0.7%) | 14,764 | 3.3 | 27.8 | 7.2 | 7.1 |
| CAPLIPOINT | 1302.3(-0.4%) | 9,820 | 4.7 | 23.5 | 26.8 | 23.7 |
| GRANULES | 392.85(2.8%) | 9,518 | 3.2 | 24.2 | 17.4 | 17.5 |
| MEDPLUS | 797.2(0.3%) | 9,468 | 6.2 | 162.3 | 9.6 | 3.5 |
| PGHL | 5128.25(0.0%) | 8,519 | 10.5 | 36.8 | 46.1 | 33.9 |
| SUVENPHAR | 674.35(2.4%) | 17,160 | 8.9 | 39.7 | 33.4 | 25.2 |
| GLS | 636.9(0.5%) | 7,798 | 3.3 | 15.4 | 30.0 | 22.3 |
| MARKSANS | 166.25(-0.4%) | 7,504 | 4.0 | 25.2 | 22.9 | 18.6 |
| JUBLPHARMA | 453.05(0.0%) | 7,210 | 1.3 | 0.0 | 2.5 | -1.2 |
| NEULANDLAB | 5370.65(-0.2%) | 6,875 | 6.1 | 25.8 | 20.9 | 17.8 |
| FDC | 397.15(-0.4%) | 6,453 | 3.3 | 25.7 | 13.2 | 9.8 |
| PFIZER | 4101.4(-0.1%) | 18,749 | 5.3 | 136.7 | 27.6 | 20.6 |
